Congresswoman Laura Richardson applauds the recent passage of the Bipartisan Food and Drug Administration Act of 2012, a bill that improves the safety, development, and distribution of medications and medical devices to patients and medical providers. The bill modifies the Food and Drug Administration's (FDA) policies and procedures to enhance Americans access to effective healthcare.
"This bill is important because it improves the safety of medication for our people, and especially our children," said Congresswoman Laura Richardson. "It gives the FDA the funding and authority it needs to effectively regulate and administer treatments to Americans in need," Congresswoman Richardson stated.
The bill reauthorizes the FDA's user fee program for prescription drugs and medical devices, which provides funding to the FDA, as well as two pediatric drug programs. These programs, enacted by the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, improve the safety and development of medications for children.
Additionally, the bill increases the FDA's authority over the global supply chain of drugs, improving regulation requirements and expanding the jurisdiction of the Federal Food, Drug and Cosmetic Act to include foreign entities. These changes improve the safety and security of the prescription drugs that are provided to patients all over the country.
"I am pleased to see this bill pass through the House," stated Congresswoman Richardson. "As a member of the Congressional 21st Century Health Care Caucus, as well as the Congressional Children's Health Care Caucus, I am proud to have worked to ensure that the wellbeing of Americans is protected," said Congresswoman Richardson.